The invention provides a compound of formula (I):
(wherein:
R
1
is an optionally substituted 2-(1-azathiaxanthone);
each —R
2
is independently of the formula —CH
2
—C(═O)—R
4
, wherein R
4
is an amino acid or a salt thereof, attached to the remainder of R
2
through the nitrogen atom of the amino group; and
R
3
is hydrogen or a C
1-6
alkyl group); or
(wherein:
R
1
is an optionally substituted 2-(1-azaxanthone);
each R
2
is independently an optionally substituted glutaric or succinic acid, or a salt or ester thereof; and
R
3
is hydrogen or a C
1-6
alkyl group).
US8628978B2
申请人:——
公开号:US8628978B2
公开(公告)日:2014-01-14
US9448225B2
申请人:——
公开号:US9448225B2
公开(公告)日:2016-09-20
A europium luminescence assay of lactate and citrate in biological fluids
作者:Robert Pal、David Parker、Leslie C. Costello
DOI:10.1039/b901251f
日期:——
Ratiometric methods of analysis have been developed for the selective determination of lactate or citrate in microlitre samples of human serum, urine or prostate fluids following comparison of anion binding affinities for a family of nine luminescent europium(III) complexes.
[EN] LUMINESCENT LANTHANIDE COMPLEXES<br/>[FR] COMPLEXES LUMINESCENTS DE LANTHANIDES
申请人:UNIV DURHAM
公开号:WO2010086615A1
公开(公告)日:2010-08-05
The invention provides a compound of formula (I): wherein: R1 is an optionally substituted 2-(1-azathiaxanthone); each -R2 is independently of the formula -CH2-C(=O)-R4, wherein R4 is an amino acid or a salt thereof, attached to the remainder of R2 through the nitrogen atom of the amino group; and R3 is hydrogen or a C1-6 alkyl group); or (wherein: R1 is an optionally substituted 2-(1-azaxanthone); each R2 is independently an optionally substituted glutaric or succinic acid, or a salt or ester thereof; and R3 is hydrogen or a C1-6 alkyl group).